OTCPK:UMTAF (China)
Â
Shs Unitary 144A/Reg S
$
0.60
0 (0%)
11:09 PM EST
Business Description
Genertec Universal Medical Group Co Ltd
ISIN : HK0000255361
Share Class Description:
UMTAF: Shs Unitary 144A/Reg SCompare
Compare
Traded in other countries / regions
02666.Hong Kong5UM.GermanyUMTAF.USA IPO Date
2017-08-03Description
Genertec Universal Medical Group Co Ltd is principally engaged in providing financing to its customers under finance lease arrangements, the provision of advisory services, the sale of medical equipment as well as leases under operating lease arrangements, and the provision of other services. The Group has two business segments; The finance business comprises direct finance leasing, sale-and-leaseback, factoring, operating leases, and advisory services, and Healthcare business comprises includes integrated healthcare services as well as specialties and healthcare industry business. Geographically, it derives a majority of its revenue from Mainland China.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.06 | |||||
| Equity-to-Asset | 0.23 | |||||
| Debt-to-Equity | 2.64 | |||||
| Debt-to-EBITDA | 14.33 | |||||
| Interest Coverage | 69.72 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 0.38 | |||||
| Beneish M-Score | -2.55 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.8 | |||||
| 3-Year EBITDA Growth Rate | -0.9 | |||||
| 3-Year EPS without NRI Growth Rate | -6.2 | |||||
| 3-Year Book Growth Rate | 5.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 7.45 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.36 | |||||
| Quick Ratio | 1.34 | |||||
| Cash Ratio | 0.11 | |||||
| Days Inventory | 17.05 | |||||
| Days Sales Outstanding | 769.65 | |||||
| Days Payable | 107.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | 3 | |||||
| 3-Year Average Share Buyback Ratio | -3.3 | |||||
| Shareholder Yield % | 28.29 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 33.91 | |||||
| Operating Margin % | 23.07 | |||||
| Net Margin % | 15.92 | |||||
| FCF Margin % | 39.44 | |||||
| ROE % | 12.04 | |||||
| ROA % | 2.58 | |||||
| ROIC % | 3.22 | |||||
| ROC (Joel Greenblatt) % | 10.39 | |||||
| ROCE % | 5.44 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 4.43 | |||||
| Forward PE Ratio | 3.55 | |||||
| PE Ratio without NRI | 4.6 | |||||
| Shiller PE Ratio | 5.43 | |||||
| Price-to-Owner-Earnings | 5.11 | |||||
| PEG Ratio | 0.71 | |||||
| PS Ratio | 0.69 | |||||
| PB Ratio | 0.45 | |||||
| Price-to-Tangible-Book | 0.46 | |||||
| Price-to-Free-Cash-Flow | 1.8 | |||||
| Price-to-Operating-Cash-Flow | 1.47 | |||||
| EV-to-EBIT | 19.7 | |||||
| EV-to-EBITDA | 16.73 | |||||
| EV-to-Revenue | 4.34 | |||||
| EV-to-FCF | 11 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.72 | |||||
| Price-to-Graham-Number | 0.31 | |||||
| Earnings Yield (Greenblatt) % | 5.08 | |||||
| FCF Yield % | 62.13 | |||||
| Forward Rate of Return (Yacktman) % | -8.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:UMTAF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genertec Universal Medical Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1,869.769 | ||
| EPS (TTM) ($) | 0.064 | ||
| Beta | 0 | ||
| Volatility % | 7.53 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 0.595 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 0.595 - 0.595 | ||
| Shares Outstanding (Mil) | 1,891.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Genertec Universal Medical Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Genertec Universal Medical Group Co Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Genertec Universal Medical Group Co Ltd Frequently Asked Questions
What is Genertec Universal Medical Group Co Ltd(UMTAF)'s stock price today?
The current price of UMTAF is $0.60. The 52 week high of UMTAF is $0.60 and 52 week low is $0.60.
When is next earnings date of Genertec Universal Medical Group Co Ltd(UMTAF)?
The next earnings date of Genertec Universal Medical Group Co Ltd(UMTAF) is .
Does Genertec Universal Medical Group Co Ltd(UMTAF) pay dividends? If so, how much?
Genertec Universal Medical Group Co Ltd(UMTAF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers